to-BBB announces collaboration with Genzyme on brain delivery of biologics for neurodegenerative diseases
04-Nov-2009 -
to-BBB, the Dutch brain drug delivery company, has entered into a research collaboration with Genzyme Corporation to evaluate to-BBB’s proprietary G-Technology™ to safely enhance delivery of biologics for neurodegenerative diseases.
The disease modifying properties of biological drugs, like ...
antibodies
biologics
brain diseases
+6